Loading stock data…
CVRx (CVRX)
$5.94+0.08 (+1.37%)
Market ClosedLast close Jun 29
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
CVRx, Inc. in the Healthcare sector is trading at $5.94 with a market capitalization of $129M. Wall Street consensus targets $11.17 (6 analysts), implying a +88.0% move over the next 12 months. The stock is currently 47% below its 52-week high of $11.30, remaining 22.4% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 45/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +88.0% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $14.77M↓ | $16.02M↑ | $14.69M↑ | $13.59M↑ | $12.35M |
| Gross Profit | $12.88M↓ | $13.82M↑ | $12.75M↑ | $11.45M↑ | $10.31M |
| Operating Income | -$12.16M↓ | -$11.18M↑ | -$12.27M↑ | -$14.38M↓ | -$13.44M |
| Net Income | -$13.12M↓ | -$11.93M↑ | -$12.87M↑ | -$14.74M↓ | -$13.77M |
Peer Comparison
JNJUNHPFE
Fundamentals
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offer...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$129.23M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-180.91%
Volume
Today's trading volume
341,666
Recent News
CVRx (CVRX) Moves 11.6% Higher: Will This Strength Last?
CVRx (CVRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy
CVRX stock gains after Humana adds Medicare Advantage coverage for Barostim therapy, boosting reimbursement momentum and patient access.
Analysts Have Made A Financial Statement On CVRx, Inc.'s (NASDAQ:CVRX) First-Quarter Report
There's been a major selloff in CVRx, Inc. ( NASDAQ:CVRX ) shares in the week since it released its quarterly report...
Down 31.7% in 4 Weeks, Here's Why You Should You Buy the Dip in CVRx (CVRX)
CVRx (CVRX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
CVRx Inc (CVRX) Q1 2026 Earnings Call Highlights: Strong U.S. Growth and Market Expansion Potential
CVRx Inc (CVRX) reports a 22% growth in the U.S., advances in reimbursement, and a promising market expansion with the BENEFIT-HF trial.